nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Lamivudine—hepatitis B	0.444	1	CrCtD
Gemcitabine—CMPK1—Lamivudine—hepatitis B	0.182	0.784	CbGbCtD
Gemcitabine—Zalcitabine—Lamivudine—hepatitis B	0.0899	0.337	CrCrCtD
Gemcitabine—Decitabine—Entecavir—hepatitis B	0.0516	0.194	CrCrCtD
Gemcitabine—DCK—Lamivudine—hepatitis B	0.0465	0.2	CbGbCtD
Gemcitabine—Cytarabine—Lamivudine—hepatitis B	0.0432	0.162	CrCrCtD
Gemcitabine—Decitabine—Telbivudine—hepatitis B	0.0427	0.16	CrCrCtD
Gemcitabine—Decitabine—Lamivudine—hepatitis B	0.0391	0.147	CrCrCtD
Gemcitabine—ABCB1—Lamivudine—hepatitis B	0.00357	0.0154	CbGbCtD
Gemcitabine—Disease progression—Telbivudine—hepatitis B	0.00209	0.0533	CcSEcCtD
Gemcitabine—Hypoxemia—Lamivudine—hepatitis B	0.00128	0.0327	CcSEcCtD
Gemcitabine—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.000942	0.024	CcSEcCtD
Gemcitabine—Transaminases increased—Entecavir—hepatitis B	0.000911	0.0233	CcSEcCtD
Gemcitabine—SLC28A1—liver—hepatitis B	0.000735	0.0815	CbGeAlD
Gemcitabine—POLD1—Global Genomic NER (GG-NER)—DDB1—hepatitis B	0.00069	0.0699	CbGpPWpGaD
Gemcitabine—POLE—Global Genomic NER (GG-NER)—DDB1—hepatitis B	0.000666	0.0675	CbGpPWpGaD
Gemcitabine—Influenza-like symptoms—Telbivudine—hepatitis B	0.000638	0.0163	CcSEcCtD
Gemcitabine—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000568	0.0145	CcSEcCtD
Gemcitabine—Bone pain—Adefovir Dipivoxil—hepatitis B	0.000565	0.0144	CcSEcCtD
Gemcitabine—CDA—blood—hepatitis B	0.000562	0.0623	CbGeAlD
Gemcitabine—Raised liver function tests—Lamivudine—hepatitis B	0.000556	0.0142	CcSEcCtD
Gemcitabine—SLC29A2—blood—hepatitis B	0.000525	0.0582	CbGeAlD
Gemcitabine—Tenderness—Telbivudine—hepatitis B	0.000522	0.0133	CcSEcCtD
Gemcitabine—POLD1—Nucleotide Excision Repair—DDB1—hepatitis B	0.000507	0.0514	CbGpPWpGaD
Gemcitabine—CMPK1—blood—hepatitis B	0.000499	0.0554	CbGeAlD
Gemcitabine—POLE—Nucleotide Excision Repair—DDB1—hepatitis B	0.000489	0.0496	CbGpPWpGaD
Gemcitabine—POLD1—liver—hepatitis B	0.000489	0.0543	CbGeAlD
Gemcitabine—CDA—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000478	0.0485	CbGpPWpGaD
Gemcitabine—POLE—blood—hepatitis B	0.000468	0.0519	CbGeAlD
Gemcitabine—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.000449	0.0115	CcSEcCtD
Gemcitabine—Hepatic failure—Entecavir—hepatitis B	0.000448	0.0114	CcSEcCtD
Gemcitabine—Influenza like illness—Telbivudine—hepatitis B	0.000442	0.0113	CcSEcCtD
Gemcitabine—CDA—liver—hepatitis B	0.000439	0.0487	CbGeAlD
Gemcitabine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.000437	0.0112	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Entecavir—hepatitis B	0.000416	0.0106	CcSEcCtD
Gemcitabine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.000413	0.0105	CcSEcCtD
Gemcitabine—SLC29A2—liver—hepatitis B	0.000411	0.0455	CbGeAlD
Gemcitabine—Hypoxia—Lamivudine—hepatitis B	0.000404	0.0103	CcSEcCtD
Gemcitabine—POLA1—blood—hepatitis B	0.000403	0.0447	CbGeAlD
Gemcitabine—Sepsis—Telbivudine—hepatitis B	0.000395	0.0101	CcSEcCtD
Gemcitabine—CMPK1—liver—hepatitis B	0.000391	0.0433	CbGeAlD
Gemcitabine—RRM2—blood—hepatitis B	0.000385	0.0427	CbGeAlD
Gemcitabine—Blood creatinine increased—Entecavir—hepatitis B	0.000377	0.00963	CcSEcCtD
Gemcitabine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000368	0.00939	CcSEcCtD
Gemcitabine—POLE—liver—hepatitis B	0.000366	0.0406	CbGeAlD
Gemcitabine—RRM1—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000363	0.0367	CbGpPWpGaD
Gemcitabine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.000363	0.00926	CcSEcCtD
Gemcitabine—Renal impairment—Telbivudine—hepatitis B	0.000347	0.00887	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.000346	0.00884	CcSEcCtD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000332	0.0336	CbGpPWpGaD
Gemcitabine—Neutropenia—Entecavir—hepatitis B	0.000325	0.0083	CcSEcCtD
Gemcitabine—RRM1—blood—hepatitis B	0.00032	0.0355	CbGeAlD
Gemcitabine—POLA1—liver—hepatitis B	0.000315	0.035	CbGeAlD
Gemcitabine—Hyperglycaemia—Entecavir—hepatitis B	0.000314	0.00801	CcSEcCtD
Gemcitabine—Renal failure—Entecavir—hepatitis B	0.000305	0.00778	CcSEcCtD
Gemcitabine—RRM2—liver—hepatitis B	0.000301	0.0334	CbGeAlD
Gemcitabine—RRM2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000299	0.0303	CbGpPWpGaD
Gemcitabine—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000298	0.0076	CcSEcCtD
Gemcitabine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000297	0.00759	CcSEcCtD
Gemcitabine—Haematuria—Entecavir—hepatitis B	0.000296	0.00755	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Entecavir—hepatitis B	0.000293	0.00749	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000292	0.00744	CcSEcCtD
Gemcitabine—TYMS—blood—hepatitis B	0.00029	0.0322	CbGeAlD
Gemcitabine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.000289	0.00737	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000286	0.00731	CcSEcCtD
Gemcitabine—Influenza—Telbivudine—hepatitis B	0.000286	0.0073	CcSEcCtD
Gemcitabine—Bone disorder—Lamivudine—hepatitis B	0.000284	0.00726	CcSEcCtD
Gemcitabine—Drug interaction—Lamivudine—hepatitis B	0.000277	0.00706	CcSEcCtD
Gemcitabine—Oedema peripheral—Entecavir—hepatitis B	0.000274	0.007	CcSEcCtD
Gemcitabine—Hearing impaired—Lamivudine—hepatitis B	0.00027	0.00688	CcSEcCtD
Gemcitabine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00027	0.00688	CcSEcCtD
Gemcitabine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000268	0.00685	CcSEcCtD
Gemcitabine—Neutropenia—Telbivudine—hepatitis B	0.000267	0.00682	CcSEcCtD
Gemcitabine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000267	0.00682	CcSEcCtD
Gemcitabine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000266	0.0068	CcSEcCtD
Gemcitabine—POLD1—DNA Repair—DDB1—hepatitis B	0.000264	0.0267	CbGpPWpGaD
Gemcitabine—Vasculitis—Lamivudine—hepatitis B	0.000263	0.00671	CcSEcCtD
Gemcitabine—SLC29A1—blood—hepatitis B	0.00026	0.0289	CbGeAlD
Gemcitabine—POLE—DNA Repair—DDB1—hepatitis B	0.000255	0.0258	CbGpPWpGaD
Gemcitabine—Immune system disorder—Entecavir—hepatitis B	0.000252	0.00642	CcSEcCtD
Gemcitabine—Renal failure—Telbivudine—hepatitis B	0.00025	0.00639	CcSEcCtD
Gemcitabine—RRM1—liver—hepatitis B	0.00025	0.0278	CbGeAlD
Gemcitabine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00025	0.00638	CcSEcCtD
Gemcitabine—DCK—blood—hepatitis B	0.000249	0.0276	CbGeAlD
Gemcitabine—Alopecia—Entecavir—hepatitis B	0.000246	0.00628	CcSEcCtD
Gemcitabine—Neuropathy—Lamivudine—hepatitis B	0.000241	0.00615	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Telbivudine—hepatitis B	0.000241	0.00615	CcSEcCtD
Gemcitabine—ABCC10—blood—hepatitis B	0.000237	0.0263	CbGeAlD
Gemcitabine—Back pain—Adefovir Dipivoxil—hepatitis B	0.000229	0.00584	CcSEcCtD
Gemcitabine—Pharyngitis—Telbivudine—hepatitis B	0.000227	0.0058	CcSEcCtD
Gemcitabine—TYMS—liver—hepatitis B	0.000227	0.0252	CbGeAlD
Gemcitabine—Connective tissue disorder—Telbivudine—hepatitis B	0.000225	0.00574	CcSEcCtD
Gemcitabine—Sepsis—Lamivudine—hepatitis B	0.000223	0.00569	CcSEcCtD
Gemcitabine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000219	0.00558	CcSEcCtD
Gemcitabine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000218	0.0221	CbGpPWpGaD
Gemcitabine—Leukopenia—Entecavir—hepatitis B	0.000217	0.00554	CcSEcCtD
Gemcitabine—Deafness—Lamivudine—hepatitis B	0.000208	0.00532	CcSEcCtD
Gemcitabine—Cough—Adefovir Dipivoxil—hepatitis B	0.000206	0.00527	CcSEcCtD
Gemcitabine—Mediastinal disorder—Telbivudine—hepatitis B	0.000206	0.00526	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000205	0.00523	CcSEcCtD
Gemcitabine—SLC29A1—liver—hepatitis B	0.000204	0.0226	CbGeAlD
Gemcitabine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000201	0.00514	CcSEcCtD
Gemcitabine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000201	0.00514	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0002	0.0051	CcSEcCtD
Gemcitabine—Anaphylactic shock—Entecavir—hepatitis B	0.000198	0.00505	CcSEcCtD
Gemcitabine—Infection—Entecavir—hepatitis B	0.000197	0.00502	CcSEcCtD
Gemcitabine—Renal impairment—Lamivudine—hepatitis B	0.000196	0.005	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000196	0.0198	CbGpPWpGaD
Gemcitabine—DCK—liver—hepatitis B	0.000194	0.0216	CbGeAlD
Gemcitabine—Nervous system disorder—Entecavir—hepatitis B	0.000194	0.00495	CcSEcCtD
Gemcitabine—Back pain—Telbivudine—hepatitis B	0.000193	0.00492	CcSEcCtD
Gemcitabine—Skin disorder—Entecavir—hepatitis B	0.000192	0.00491	CcSEcCtD
Gemcitabine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000189	0.00483	CcSEcCtD
Gemcitabine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000189	0.00482	CcSEcCtD
Gemcitabine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000187	0.00479	CcSEcCtD
Gemcitabine—ABCB1—blood plasma—hepatitis B	0.000187	0.0207	CbGeAlD
Gemcitabine—ABCC10—liver—hepatitis B	0.000185	0.0205	CbGeAlD
Gemcitabine—Ill-defined disorder—Telbivudine—hepatitis B	0.000185	0.00472	CcSEcCtD
Gemcitabine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000184	0.0047	CcSEcCtD
Gemcitabine—Malaise—Telbivudine—hepatitis B	0.00018	0.00458	CcSEcCtD
Gemcitabine—Insomnia—Entecavir—hepatitis B	0.000179	0.00457	CcSEcCtD
Gemcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000177	0.018	CbGpPWpGaD
Gemcitabine—Somnolence—Entecavir—hepatitis B	0.000176	0.00449	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000176	0.00449	CcSEcCtD
Gemcitabine—Cough—Telbivudine—hepatitis B	0.000174	0.00444	CcSEcCtD
Gemcitabine—Liver function test abnormal—Lamivudine—hepatitis B	0.000172	0.00439	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Entecavir—hepatitis B	0.000171	0.00436	CcSEcCtD
Gemcitabine—Fatigue—Entecavir—hepatitis B	0.000171	0.00435	CcSEcCtD
Gemcitabine—Chest pain—Telbivudine—hepatitis B	0.00017	0.00433	CcSEcCtD
Gemcitabine—Myalgia—Telbivudine—hepatitis B	0.00017	0.00433	CcSEcCtD
Gemcitabine—Arthralgia—Telbivudine—hepatitis B	0.00017	0.00433	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000168	0.0043	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000168	0.00428	CcSEcCtD
Gemcitabine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000168	0.00428	CcSEcCtD
Gemcitabine—Discomfort—Telbivudine—hepatitis B	0.000167	0.00428	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000167	0.00425	CcSEcCtD
Gemcitabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000165	0.0167	CbGpPWpGaD
Gemcitabine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000164	0.0042	CcSEcCtD
Gemcitabine—Influenza—Lamivudine—hepatitis B	0.000161	0.00411	CcSEcCtD
Gemcitabine—Nervous system disorder—Telbivudine—hepatitis B	0.000159	0.00407	CcSEcCtD
Gemcitabine—Thrombocytopenia—Telbivudine—hepatitis B	0.000159	0.00406	CcSEcCtD
Gemcitabine—Skin disorder—Telbivudine—hepatitis B	0.000158	0.00403	CcSEcCtD
Gemcitabine—Body temperature increased—Entecavir—hepatitis B	0.000156	0.00399	CcSEcCtD
Gemcitabine—Pancytopenia—Lamivudine—hepatitis B	0.000153	0.0039	CcSEcCtD
Gemcitabine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000153	0.0039	CcSEcCtD
Gemcitabine—Neutropenia—Lamivudine—hepatitis B	0.000151	0.00384	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000148	0.00378	CcSEcCtD
Gemcitabine—Insomnia—Telbivudine—hepatitis B	0.000147	0.00375	CcSEcCtD
Gemcitabine—Paraesthesia—Telbivudine—hepatitis B	0.000146	0.00373	CcSEcCtD
Gemcitabine—Hyperglycaemia—Lamivudine—hepatitis B	0.000145	0.00371	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000142	0.00363	CcSEcCtD
Gemcitabine—Asthenia—Entecavir—hepatitis B	0.000142	0.00362	CcSEcCtD
Gemcitabine—Renal failure—Lamivudine—hepatitis B	0.000141	0.0036	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Lamivudine—hepatitis B	0.000141	0.00359	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00014	0.00358	CcSEcCtD
Gemcitabine—Fatigue—Telbivudine—hepatitis B	0.00014	0.00358	CcSEcCtD
Gemcitabine—Stomatitis—Lamivudine—hepatitis B	0.00014	0.00357	CcSEcCtD
Gemcitabine—Pain—Telbivudine—hepatitis B	0.000139	0.00355	CcSEcCtD
Gemcitabine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000138	0.00354	CcSEcCtD
Gemcitabine—Sweating—Lamivudine—hepatitis B	0.000138	0.00351	CcSEcCtD
Gemcitabine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000137	0.00349	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Lamivudine—hepatitis B	0.000136	0.00347	CcSEcCtD
Gemcitabine—Diarrhoea—Entecavir—hepatitis B	0.000135	0.00346	CcSEcCtD
Gemcitabine—Agranulocytosis—Lamivudine—hepatitis B	0.000134	0.00342	CcSEcCtD
Gemcitabine—Feeling abnormal—Telbivudine—hepatitis B	0.000134	0.00342	CcSEcCtD
Gemcitabine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000132	0.00337	CcSEcCtD
Gemcitabine—Rhinitis—Lamivudine—hepatitis B	0.000129	0.0033	CcSEcCtD
Gemcitabine—Body temperature increased—Telbivudine—hepatitis B	0.000128	0.00328	CcSEcCtD
Gemcitabine—Pharyngitis—Lamivudine—hepatitis B	0.000128	0.00327	CcSEcCtD
Gemcitabine—Connective tissue disorder—Lamivudine—hepatitis B	0.000127	0.00323	CcSEcCtD
Gemcitabine—Vomiting—Entecavir—hepatitis B	0.000126	0.00321	CcSEcCtD
Gemcitabine—Rash—Entecavir—hepatitis B	0.000125	0.00318	CcSEcCtD
Gemcitabine—Dermatitis—Entecavir—hepatitis B	0.000125	0.00318	CcSEcCtD
Gemcitabine—Headache—Entecavir—hepatitis B	0.000124	0.00316	CcSEcCtD
Gemcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000123	0.0125	CbGpPWpGaD
Gemcitabine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000123	0.00313	CcSEcCtD
Gemcitabine—Erythema multiforme—Lamivudine—hepatitis B	0.000122	0.00311	CcSEcCtD
Gemcitabine—Rash—Adefovir Dipivoxil—hepatitis B	0.000122	0.00311	CcSEcCtD
Gemcitabine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000122	0.0031	CcSEcCtD
Gemcitabine—Headache—Adefovir Dipivoxil—hepatitis B	0.000121	0.00309	CcSEcCtD
Gemcitabine—Nausea—Entecavir—hepatitis B	0.000118	0.003	CcSEcCtD
Gemcitabine—Asthenia—Telbivudine—hepatitis B	0.000117	0.00298	CcSEcCtD
Gemcitabine—Immune system disorder—Lamivudine—hepatitis B	0.000116	0.00297	CcSEcCtD
Gemcitabine—Mediastinal disorder—Lamivudine—hepatitis B	0.000116	0.00297	CcSEcCtD
Gemcitabine—Chills—Lamivudine—hepatitis B	0.000116	0.00295	CcSEcCtD
Gemcitabine—Pruritus—Telbivudine—hepatitis B	0.000115	0.00294	CcSEcCtD
Gemcitabine—Nausea—Adefovir Dipivoxil—hepatitis B	0.000115	0.00293	CcSEcCtD
Gemcitabine—Alopecia—Lamivudine—hepatitis B	0.000114	0.00291	CcSEcCtD
Gemcitabine—Erythema—Lamivudine—hepatitis B	0.000112	0.00286	CcSEcCtD
Gemcitabine—Diarrhoea—Telbivudine—hepatitis B	0.000111	0.00284	CcSEcCtD
Gemcitabine—Back pain—Lamivudine—hepatitis B	0.000109	0.00277	CcSEcCtD
Gemcitabine—Ill-defined disorder—Lamivudine—hepatitis B	0.000104	0.00266	CcSEcCtD
Gemcitabine—Anaemia—Lamivudine—hepatitis B	0.000104	0.00265	CcSEcCtD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—hepatitis B	0.000103	0.0105	CbGpPWpGaD
Gemcitabine—Vomiting—Telbivudine—hepatitis B	0.000103	0.00264	CcSEcCtD
Gemcitabine—Rash—Telbivudine—hepatitis B	0.000102	0.00262	CcSEcCtD
Gemcitabine—Dermatitis—Telbivudine—hepatitis B	0.000102	0.00261	CcSEcCtD
Gemcitabine—Headache—Telbivudine—hepatitis B	0.000102	0.0026	CcSEcCtD
Gemcitabine—Malaise—Lamivudine—hepatitis B	0.000101	0.00258	CcSEcCtD
Gemcitabine—Leukopenia—Lamivudine—hepatitis B	0.0001	0.00256	CcSEcCtD
Gemcitabine—Cough—Lamivudine—hepatitis B	9.79e-05	0.0025	CcSEcCtD
Gemcitabine—Nausea—Telbivudine—hepatitis B	9.65e-05	0.00246	CcSEcCtD
Gemcitabine—Arthralgia—Lamivudine—hepatitis B	9.55e-05	0.00244	CcSEcCtD
Gemcitabine—Myalgia—Lamivudine—hepatitis B	9.55e-05	0.00244	CcSEcCtD
Gemcitabine—Chest pain—Lamivudine—hepatitis B	9.55e-05	0.00244	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	9.49e-05	0.00242	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	9.47e-05	0.00959	CbGpPWpGaD
Gemcitabine—Discomfort—Lamivudine—hepatitis B	9.44e-05	0.00241	CcSEcCtD
Gemcitabine—Oedema—Lamivudine—hepatitis B	9.16e-05	0.00234	CcSEcCtD
Gemcitabine—Anaphylactic shock—Lamivudine—hepatitis B	9.16e-05	0.00234	CcSEcCtD
Gemcitabine—Infection—Lamivudine—hepatitis B	9.1e-05	0.00232	CcSEcCtD
Gemcitabine—Nervous system disorder—Lamivudine—hepatitis B	8.98e-05	0.00229	CcSEcCtD
Gemcitabine—Thrombocytopenia—Lamivudine—hepatitis B	8.97e-05	0.00229	CcSEcCtD
Gemcitabine—Skin disorder—Lamivudine—hepatitis B	8.9e-05	0.00227	CcSEcCtD
Gemcitabine—Hyperhidrosis—Lamivudine—hepatitis B	8.85e-05	0.00226	CcSEcCtD
Gemcitabine—Anorexia—Lamivudine—hepatitis B	8.73e-05	0.00223	CcSEcCtD
Gemcitabine—Hypotension—Lamivudine—hepatitis B	8.56e-05	0.00218	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Lamivudine—hepatitis B	8.34e-05	0.00213	CcSEcCtD
Gemcitabine—Insomnia—Lamivudine—hepatitis B	8.28e-05	0.00211	CcSEcCtD
Gemcitabine—Paraesthesia—Lamivudine—hepatitis B	8.22e-05	0.0021	CcSEcCtD
Gemcitabine—Dyspnoea—Lamivudine—hepatitis B	8.17e-05	0.00208	CcSEcCtD
Gemcitabine—Somnolence—Lamivudine—hepatitis B	8.14e-05	0.00208	CcSEcCtD
Gemcitabine—Decreased appetite—Lamivudine—hepatitis B	7.96e-05	0.00203	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Lamivudine—hepatitis B	7.91e-05	0.00202	CcSEcCtD
Gemcitabine—Fatigue—Lamivudine—hepatitis B	7.9e-05	0.00202	CcSEcCtD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—hepatitis B	7.84e-05	0.00794	CbGpPWpGaD
Gemcitabine—Constipation—Lamivudine—hepatitis B	7.83e-05	0.002	CcSEcCtD
Gemcitabine—Pain—Lamivudine—hepatitis B	7.83e-05	0.002	CcSEcCtD
Gemcitabine—Feeling abnormal—Lamivudine—hepatitis B	7.55e-05	0.00193	CcSEcCtD
Gemcitabine—RRM1—E2F transcription factor network—CDKN2A—hepatitis B	7.46e-05	0.00756	CbGpPWpGaD
Gemcitabine—Body temperature increased—Lamivudine—hepatitis B	7.24e-05	0.00185	CcSEcCtD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—hepatitis B	7.17e-05	0.00726	CbGpPWpGaD
Gemcitabine—ABCB1—blood—hepatitis B	6.84e-05	0.00759	CbGeAlD
Gemcitabine—Asthenia—Lamivudine—hepatitis B	6.57e-05	0.00168	CcSEcCtD
Gemcitabine—Pruritus—Lamivudine—hepatitis B	6.48e-05	0.00165	CcSEcCtD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—hepatitis B	6.46e-05	0.00654	CbGpPWpGaD
Gemcitabine—Diarrhoea—Lamivudine—hepatitis B	6.27e-05	0.0016	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN2A—hepatitis B	6.24e-05	0.00633	CbGpPWpGaD
Gemcitabine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	6.19e-05	0.00627	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—CDKN2A—hepatitis B	6.15e-05	0.00623	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—CDKN1A—hepatitis B	6.1e-05	0.00618	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKR1B1—hepatitis B	6.09e-05	0.00617	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GGT2—hepatitis B	5.83e-05	0.00591	CbGpPWpGaD
Gemcitabine—Vomiting—Lamivudine—hepatitis B	5.82e-05	0.00149	CcSEcCtD
Gemcitabine—Rash—Lamivudine—hepatitis B	5.77e-05	0.00147	CcSEcCtD
Gemcitabine—Dermatitis—Lamivudine—hepatitis B	5.77e-05	0.00147	CcSEcCtD
Gemcitabine—Headache—Lamivudine—hepatitis B	5.74e-05	0.00146	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	5.72e-05	0.00579	CbGpPWpGaD
Gemcitabine—Nausea—Lamivudine—hepatitis B	5.44e-05	0.00139	CcSEcCtD
Gemcitabine—ABCB1—liver—hepatitis B	5.35e-05	0.00593	CbGeAlD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	5.33e-05	0.0054	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	5.33e-05	0.0054	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	5.3e-05	0.00537	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.14e-05	0.00521	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	5.11e-05	0.00518	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN1A—hepatitis B	5.1e-05	0.00517	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—CDKN1A—hepatitis B	5.02e-05	0.00509	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—ALB—hepatitis B	4.67e-05	0.00474	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	4.37e-05	0.00442	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—hepatitis B	4.23e-05	0.00429	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—hepatitis B	4.2e-05	0.00426	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	4.19e-05	0.00425	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	4.08e-05	0.00413	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—hepatitis B	4.03e-05	0.00408	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—CDKN1A—hepatitis B	4.01e-05	0.00406	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—CDKN1A—hepatitis B	3.87e-05	0.00392	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—hepatitis B	3.81e-05	0.00386	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—CDKN1A—hepatitis B	3.76e-05	0.00381	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKR1B1—hepatitis B	3.76e-05	0.00381	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	3.76e-05	0.00381	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	3.69e-05	0.00374	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—CDKN1A—hepatitis B	3.65e-05	0.00369	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—CDKN1A—hepatitis B	3.63e-05	0.00368	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	3.61e-05	0.00366	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	3.61e-05	0.00366	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GGT2—hepatitis B	3.6e-05	0.00365	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—ALB—hepatitis B	3.54e-05	0.00359	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP2A6—hepatitis B	3.53e-05	0.00358	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—CDKN1A—hepatitis B	3.5e-05	0.00355	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—hepatitis B	3.48e-05	0.00352	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN1A—hepatitis B	3.44e-05	0.00348	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—CDKN1A—hepatitis B	3.29e-05	0.00334	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CDKN1A—hepatitis B	3.29e-05	0.00333	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GOT2—hepatitis B	3.2e-05	0.00324	CbGpPWpGaD
Gemcitabine—POLE—S Phase—CDKN1A—hepatitis B	3.18e-05	0.00322	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	3.07e-05	0.00311	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	3e-05	0.00304	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	2.99e-05	0.00303	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.97e-05	0.00301	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	2.95e-05	0.00299	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	2.9e-05	0.00293	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.89e-05	0.00293	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	2.88e-05	0.00292	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	2.86e-05	0.0029	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.85e-05	0.00289	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKR1B1—hepatitis B	2.85e-05	0.00289	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.83e-05	0.00286	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.82e-05	0.00286	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.81e-05	0.00284	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.78e-05	0.00281	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	2.77e-05	0.00281	CbGpPWpGaD
Gemcitabine—POLA1—Synthesis of DNA—CDKN1A—hepatitis B	2.76e-05	0.0028	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GOT1—hepatitis B	2.76e-05	0.0028	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GGT1—hepatitis B	2.76e-05	0.0028	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GGT2—hepatitis B	2.73e-05	0.00277	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—FAS—hepatitis B	2.66e-05	0.0027	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—hepatitis B	2.64e-05	0.00268	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	2.62e-05	0.00266	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—CDKN1A—hepatitis B	2.59e-05	0.00262	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	2.57e-05	0.0026	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—CDKN1A—hepatitis B	2.49e-05	0.00253	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	2.46e-05	0.0025	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—CDKN1A—hepatitis B	2.39e-05	0.00242	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ALB—hepatitis B	2.38e-05	0.00241	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKR1B1—hepatitis B	2.35e-05	0.00238	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.34e-05	0.00237	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKR1B1—hepatitis B	2.33e-05	0.00236	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NOS2—hepatitis B	2.28e-05	0.00231	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CDKN1A—hepatitis B	2.26e-05	0.00229	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GGT2—hepatitis B	2.25e-05	0.00228	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GGT2—hepatitis B	2.24e-05	0.00227	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKR1B1—hepatitis B	2.19e-05	0.00222	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP2A6—hepatitis B	2.18e-05	0.00221	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.18e-05	0.00221	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GGT2—hepatitis B	2.1e-05	0.00213	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	2.1e-05	0.00213	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	2.03e-05	0.00206	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	2.01e-05	0.00204	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GOT2—hepatitis B	1.98e-05	0.002	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	1.95e-05	0.00197	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—hepatitis B	1.94e-05	0.00196	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL10—hepatitis B	1.94e-05	0.00196	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	1.94e-05	0.00196	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.92e-05	0.00195	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ALB—hepatitis B	1.8e-05	0.00182	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FASLG—hepatitis B	1.8e-05	0.00182	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FAS—hepatitis B	1.73e-05	0.00176	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	1.71e-05	0.00174	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	1.71e-05	0.00173	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GGT1—hepatitis B	1.7e-05	0.00173	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GOT1—hepatitis B	1.7e-05	0.00173	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ALB—hepatitis B	1.69e-05	0.00171	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP2A6—hepatitis B	1.66e-05	0.00168	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.63e-05	0.00165	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.59e-05	0.00161	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.59e-05	0.00161	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.58e-05	0.0016	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	1.58e-05	0.0016	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	1.56e-05	0.00158	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	1.56e-05	0.00158	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKR1B1—hepatitis B	1.54e-05	0.00156	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	1.53e-05	0.00155	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	1.52e-05	0.00154	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	1.51e-05	0.00153	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GOT2—hepatitis B	1.5e-05	0.00152	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GGT2—hepatitis B	1.47e-05	0.00149	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ALB—hepatitis B	1.47e-05	0.00149	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—hepatitis B	1.46e-05	0.00148	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.38e-05	0.0014	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.37e-05	0.00139	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP2A6—hepatitis B	1.36e-05	0.00138	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2A6—hepatitis B	1.35e-05	0.00137	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—hepatitis B	1.34e-05	0.00136	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.32e-05	0.00134	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.32e-05	0.00133	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GGT1—hepatitis B	1.29e-05	0.00131	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GOT1—hepatitis B	1.29e-05	0.00131	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2A6—hepatitis B	1.27e-05	0.00129	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.26e-05	0.00128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GOT2—hepatitis B	1.23e-05	0.00125	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—hepatitis B	1.23e-05	0.00125	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.23e-05	0.00125	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GOT2—hepatitis B	1.23e-05	0.00124	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—hepatitis B	1.23e-05	0.00124	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—hepatitis B	1.18e-05	0.0012	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.18e-05	0.00119	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GOT2—hepatitis B	1.15e-05	0.00117	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—hepatitis B	1.14e-05	0.00115	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.13e-05	0.00114	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—hepatitis B	1.12e-05	0.00113	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.12e-05	0.00113	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.08e-05	0.0011	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.08e-05	0.0011	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GGT1—hepatitis B	1.06e-05	0.00108	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GOT1—hepatitis B	1.06e-05	0.00108	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GGT1—hepatitis B	1.06e-05	0.00107	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GOT1—hepatitis B	1.06e-05	0.00107	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.04e-05	0.00105	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—hepatitis B	1.01e-05	0.00102	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—hepatitis B	1.01e-05	0.00102	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—hepatitis B	1e-05	0.00101	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—hepatitis B	9.97e-06	0.00101	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GGT1—hepatitis B	9.94e-06	0.00101	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GOT1—hepatitis B	9.94e-06	0.00101	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—hepatitis B	9.67e-06	0.00098	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—hepatitis B	9.43e-06	0.000955	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—hepatitis B	9.12e-06	0.000925	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—hepatitis B	9.07e-06	0.000919	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—hepatitis B	9.03e-06	0.000915	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2A6—hepatitis B	8.93e-06	0.000905	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	8.88e-06	0.000899	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	8.56e-06	0.000867	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—hepatitis B	8.43e-06	0.000854	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GOT2—hepatitis B	8.08e-06	0.000818	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—hepatitis B	8.08e-06	0.000818	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	7.89e-06	0.000799	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—hepatitis B	7.71e-06	0.000781	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—hepatitis B	7.38e-06	0.000748	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—hepatitis B	7.36e-06	0.000746	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GGT1—hepatitis B	6.97e-06	0.000706	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GOT1—hepatitis B	6.97e-06	0.000706	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—hepatitis B	6.92e-06	0.000701	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—hepatitis B	6.89e-06	0.000698	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—hepatitis B	6.87e-06	0.000696	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—hepatitis B	6.86e-06	0.000695	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—hepatitis B	6.82e-06	0.000691	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—hepatitis B	6.6e-06	0.000669	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—hepatitis B	6.58e-06	0.000667	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—hepatitis B	5.66e-06	0.000573	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—hepatitis B	5.63e-06	0.00057	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—hepatitis B	5.29e-06	0.000536	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—hepatitis B	5.24e-06	0.000531	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.82e-06	0.000488	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKR1B1—hepatitis B	4.74e-06	0.000481	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.71e-06	0.000477	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4.69e-06	0.000476	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—hepatitis B	4.69e-06	0.000475	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	4.67e-06	0.000473	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GGT2—hepatitis B	4.55e-06	0.000461	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—hepatitis B	4.49e-06	0.000455	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—hepatitis B	4.32e-06	0.000438	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—hepatitis B	4.29e-06	0.000435	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—hepatitis B	4.04e-06	0.000409	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.89e-06	0.000394	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—hepatitis B	3.71e-06	0.000376	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.63e-06	0.000368	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.2e-06	0.000325	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—hepatitis B	2.83e-06	0.000287	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2A6—hepatitis B	2.76e-06	0.000279	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GOT2—hepatitis B	2.49e-06	0.000253	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.44e-06	0.000248	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GOT1—hepatitis B	2.15e-06	0.000218	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GGT1—hepatitis B	2.15e-06	0.000218	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—hepatitis B	1.14e-06	0.000116	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—hepatitis B	8.73e-07	8.85e-05	CbGpPWpGaD
